FDA panel recommends approval of telaprevir for hepatitis C. PDF Print
FDA: Although tests revealed side effects such as anemia and rashes, the panel praised the drug’s apparent 80 percent cure rate for the virus, up from 40 percent for current treatments.

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.